Free Daily Podcast Summary
Lung Cancer Considered: Daily Summaries Delivered
by IASLC
Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.Lung Cancer considered is funded in part by Current sponsors: • AbbVie • AstraZeneca• Gilead• J&J• Summit
Latest Episodes
The most recent episodes — sign up to get AI-powered summaries of each one.
- Today39 min
LCC: ESMO Highlights in Spanish
LCC in Spanish: ESMO 2026 Highlights En este episodio en español de Lung Cancer Considered, la Dra. Narjust Florez conversa con la Dra. Ana Velázquez Mañana sobre los principales avances en la investigación del cáncer de pulmón presentados en ESMO 2026 en Madrid. Destacan los resultados de los estudios DeLLphi-305, SAFFRON y Krascendo 1, explorando los avances en el tratamiento del cáncer de pulmón de células pequeñas y las terapias dirigidas para el cáncer de pulmón de células no pequeñas con mutaciones de EGFR y KRAS G12C. La conversación también aborda el estudio MOIO y sus implicaciones para los intervalos de administración de la inmunoterapia, la seguridad de los tratamientos y la práctica clínica. In this Spanish-language episode of Lung Cancer Considered, host Dr. Narjust Florez welcomes Dr. Ana Velázquez Mañana to discuss key lung cancer research presented at ESMO 2026 in Madrid. They highlight findings from the DeLLphi-305, SAFFRON, and Krascendo 1 trials, exploring advances in small cell lung cancer treatment and targeted therapies for EGFR-mutated and KRAS G12C-mutated non-small cell lung cancer. The conversation also examines the MOIO trial and its implications for immunotherapy dosing intervals, treatment safety, and clinical practice.
- 2 days ago1h 26m
ESMO 2026 Highlights – Part 1
In this episode of Lung Cancer Considered, Drs. Jacob Sands, Ferdinandos Skoulidis, and Jarushka Naidoo discuss key research highlights from ESMO 2026, including results from the DeLLphi-305 trial evaluating tarlatamab in extensive-stage small cell lung cancer and the KRAScendo-1 trial investigating divarasib in KRAS G12C-mutated NSCLC. The discussion also explores emerging immunotherapy strategies, including findings from the MOIO and OptiTROP-Lung06 studies, advances in predicting immune-related toxicities, and the potential implications of these developments for clinical practice. Jaruska Naidoo, MD Professor of Medical Oncology Royal College of Surgeons Consultant, Medical Oncologist at Beaumont Hospital X: @DrJNaidoo Instagram: jarushkanaidoo LinkedIn: https://www.linkedin.com/in/jarushka-naidoo-127a3b97/ Jacob Sands, MD Assistant Professor of Medicine, Harvard Medical School Associate Chief, Lowe Center for Thoracic Oncology Dana-Farber Cancer Institute X: @sands_jacob Instagram: jacobsands LinkedIn: https://www.linkedin.com/in/jacobsands/ Ferdinandos Skoulidis, MD, PhD Professor, Department of Thoracic and Head and Neck Medical Oncology University of Texas MD Anderson Cancer Center
- 1 weeks ago25 min
LCC in Georgian: Virtual Tumor Board Advanced EGFR-positive Lung Cancer
In this Georgian-language episode of Lung Cancer Considered, Dr. Elene Mariamidze is joined by Dr. Mariam Tchiabrishvili and Dr. Lasha Khmaladze for a multidisciplinary discussion of a challenging case of EGFR-mutated non-small cell lung cancer (NSCLC). Through a case-based discussion, they explore molecular testing, treatment strategies, management of brain metastases, and the role of EGFR tyrosine kinase inhibitors (EGFR TKIs), while highlighting evolving treatment options and challenges in accessing care in Georgia. Guests: Elene Mariamidze, MD Clinical Oncologist, Todua Clinic President of Georgian School of Oncology (GSO) Mariam Tchiabrishvili, MD Radiation Oncologist Todua Clinic Tbilisi State University
- 2 weeks ago41 min
LCC in Arabic: WCLC 2026 Highlights
The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages. In this episode, host Dr. Nagla Karim moderates a discussion in Arabic about highlights from the conference with Dr. Bashir Abu Aqeel, Dr. Riad Abdel Jalil, Dr. Kamal Al-rabi, Dr. Myriam Saadi, Dr. Ahmed Magdy Rabea, and Dr. Hussein Soudy. Guests: Nagla Karim, MD Professor of Medicine Director of Thoracic Oncology and Phase I Programs George Washington University Riad Abdel Jalil, MD Thoracic Surgeon King Hussein Cancer Center Bashir Abu Aqeel, MD Medical Oncologist Augusta Victoria Hospital Kamal Al-rabi, MD Medical Oncology King Hussien Cancer Center Ahmed Magdy Rabea Assistant Professor of Medical National Cancer Institute, Cairo University Myriam Saadi, MD Assistant Professor of Medical Oncology, University of Tunis el Manar Faculty of Medicine of Tunis, Department of Medical Oncology Abderrahman Mami Hospital Hussein Soudy, MBBS, PhD Senior Consultant, Medical Oncology St. George & Sutherland Hospitals, Sydney
- 2 weeks ago1h 1m
LCC in Mandarin: WCLC 2026 Highlights with Experts from Taiwan
The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages. In this episode, guest host Dr. Kuan Yu Chen moderates a discussion in Mandarin with Dr. Bin-Chi Liao, Dr. Mong-Wei Lin, and Dr. Po-Lan Su, leading lung cancer experts in Taiwan, who share their perspectives on key highlights from the conference. Guests: Kuan-Yu Chen, MD, PhD Clinical Professor and Chief, Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine National Taiwan University Hospital and College of Medicine Bin-Chi Liao, MD Department of Medical Oncology National Taiwan University Cancer Center Mong-Wei Lin, MD, PhD Professor of Surgery, National Taiwan University College of Medicine Chief, Division of Thoracic Surgery National Taiwan University Hospital Dr. Po-Lan Su, MD, PhD Clinical Associate Professor, Department of Internal Medicine National Chung Kung University Hospital, Taiwan
- 3 weeks ago38 min
LCC in Hebrew: WCLC 2026 Highlights
The 2026 World Conference on Lung Cancer brought together leading experts, researchers, and oncologists to showcase the latest advancements in lung cancer research. To reach a global audience, IASLC has recorded podcast episodes on WCLC 2026 in world languages. In this episode, host Dr. Ory Wiesel moderates a discussion in Hebrew with Dr. Jair Bar, Dr. Nir Peled, and Dr. Hadas Sorotsky about highlights from the conference.
- 3 weeks ago18 min
WCLC 2026 Early Career Takeover: Research, Networking, and Career Growth
Recorded at the 2026 IASLC World Conference on Lung Cancer in Seoul, this special Early Career Takeover episode explores what this annual meeting offers to researchers and clinicians at the start of their careers. Dr. Sara Fra, Dr. Cassio Murilo Hidalgo Filho, and Dr. Nan Sethakorn discuss the research presented at the meeting, the value of bringing together a multidisciplinary and international community, and the networking opportunities that helped them connect with colleagues across specialties. They reflect on their experiences in the IASLC Academy and highlight specific career development opportunities including mentorship, grants, research support, and the Early Career Forum. Guests: Sara Fra, MD Thoracic Surgeon Department of Thoracic Surgery Ramón y Cajal University Hospital Cassio Murilo Hidalgo Filho, MD Medical Oncology, Postdoctoral Fellow Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute Harvard Medical School Nan Sethakorn, MD, PhD Thoracic Oncologist Basic Translational Researcher Loyola University Chicago
- 4 weeks ago37 min
LCC in Arabic: Joint IASLC/EMRO Workshop Highlights From WCLC 2026
The WHO Eastern Mediterranean Region (EMRO) faces unique challenges around exposures, non-conventional smoking, lung cancer screening, molecular profiling, and evolving therapies in lung cancer. To address this, the inaugural joint IASLC/EMRO workshop took place at the 2026 World Conference on Lung Cancer (WCLC) in Seoul. In this episode, Dr. Nagla Karim discusses highlights from the workshop in Arabic with Dr. Hesham Elghazaly, Dr. Arafat Tfayli, Dr. Bashir Abu Aqeel, Dr. Riad Abdel Jalil, Dr. Adda Bounedjar, and Dr. Rasha Aboelhassan. Guests: Nagla Karim, MD Professor of Medicine Director of Thoracic Oncology and Phase I Programs George Washington University Hesham Elghazaly, MD Professor of Clinical Oncology Ain Shams University Arafat Tfayli, MD Chief of Hematology/Oncology and Professor of Clinical Medicine American University of Beirut Medical Center Bashir Abu Aqeel, MD Medical Oncologist Augusta Victoria Hospital Riad Abdel Jalil, MD Thoracic Surgeon King Hussein Cancer Center Adda Bounedjar, MD Professor of Medical Oncology Blida 1 University Rasha Aboelhassan, MD Senior Oncology Consultant Nasser Institute for Research and Treatment
Get Lung Cancer Considered summaries in your inbox
Free AI-powered daily recaps. Key takeaways, quotes, and mentions — in a 5-minute read.
Get Free Summaries →Free forever for up to 3 podcasts. No credit card required.
You Might Also Like
Listeners also like.
INTERLUDE: Cancer Stories with Dr. Teplinsky
Eleonora Teplinsky
Out of the Gray (Gy) - Standard Imaging
Conversations with experts in radiation oncology exploring advancements in technology, research, and clinical practice.
The Internet Book of Critical Care Podcast
A podcast exploring critical care medicine through chapter discussions and evidence-based updates from The Internet Book of Critical Care.
This Week in Cardiology
A weekly summary and analysis of key developments in cardiology for healthcare professionals.
You, Me and the Big C: Putting the can in cancer
BBC Radio 5 Live
ICU Ed and Todd-Cast
Eddie and Todd
The Curbsiders Internal Medicine Podcast
Expert-led internal medicine discussions with clinical insights and humor for primary care and hospital medicine providers.
CME in Minutes: Education in Rheumatology, Immunology, & Infectious Diseases
Answers in CME
Thrive Through and Beyond Cancer
Season Johnson
A Shot in the Arm Podcast
Ben Plumley
Jon Holmes Says the C-Word
A man discusses his cancer experience with guests, sharing honest and often humorous stories about diagnosis and treatment.
Big Ideas Lab
Inside Lawrence Livermore National Laboratory, uncover breakthroughs in science and technology shaping the future.
About Lung Cancer Considered
Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.Lung Cancer considered is funded in part by Current sponsors: • AbbVie • AstraZeneca• Gilead• J&J• Summit
Customized Recaps
AI-powered recaps with compact key takeaways, quotes, and insights.
Straight to Your Inbox
Get key takeaways from Lung Cancer Considered in a 5-minute read.
Save Hours Every Week
Stay current on your favorite podcasts without falling behind.
Frequently Asked Questions
What is Podzilla's Lung Cancer Considered daily summary?
It's a free AI-powered email that summarizes new episodes of Lung Cancer Considered as soon as they're published. You get the key takeaways, notable quotes, and links & mentions — all in a quick read.
How does the Lung Cancer Considered podcast summary work?
When a new episode drops, our AI transcribes and analyzes it, then generates a personalized summary tailored to your interests and profession. It's delivered to your inbox every morning.
Is this an official Lung Cancer Considered product?
No. Podzilla is an independent service that summarizes publicly available podcast content. We're not affiliated with or endorsed by IASLC.
Can I get summaries of other podcasts too?
Absolutely! The free plan covers up to 3 podcasts, any in the catalog. Basic raises that to 15, Pro to 40 and Max to 100. Browse our full catalog at /podcasts.
How often does Lung Cancer Considered release new episodes?
Lung Cancer Considered publishes 2x weekly. Our AI generates a summary within hours of each new episode.
What topics does Lung Cancer Considered cover?
Lung Cancer Considered covers topics including Science. Our AI identifies the specific themes in each episode and highlights what matters most to you.
Start getting Lung Cancer Considered summaries tomorrow morning.
Free forever for up to 3 podcasts. No credit card required.
Free forever for up to 3 podcasts. No credit card required.